340 related articles for article (PubMed ID: 10753864)
1. SOX9 enhances aggrecan gene promoter/enhancer activity and is up-regulated by retinoic acid in a cartilage-derived cell line, TC6.
Sekiya I; Tsuji K; Koopman P; Watanabe H; Yamada Y; Shinomiya K; Nifuji A; Noda M
J Biol Chem; 2000 Apr; 275(15):10738-44. PubMed ID: 10753864
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of a single helix-loop-helix-type transcription factor, scleraxis, enhances aggrecan gene expression in osteoblastic osteosarcoma ROS17/2.8 cells.
Liu Y; Watanabe H; Nifuji A; Yamada Y; Olson EN; Noda M
J Biol Chem; 1997 Nov; 272(47):29880-5. PubMed ID: 9368062
[TBL] [Abstract][Full Text] [Related]
3. SOX9-dependent and -independent transcriptional regulation of human cartilage link protein.
Kou I; Ikegawa S
J Biol Chem; 2004 Dec; 279(49):50942-8. PubMed ID: 15456769
[TBL] [Abstract][Full Text] [Related]
4. L-Sox5 and Sox6 drive expression of the aggrecan gene in cartilage by securing binding of Sox9 to a far-upstream enhancer.
Han Y; Lefebvre V
Mol Cell Biol; 2008 Aug; 28(16):4999-5013. PubMed ID: 18559420
[TBL] [Abstract][Full Text] [Related]
5. Trans-activation of the mouse cartilage-derived retinoic acid-sensitive protein gene by Sox9.
Xie WF; Zhang X; Sakano S; Lefebvre V; Sandell LJ
J Bone Miner Res; 1999 May; 14(5):757-63. PubMed ID: 10320524
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Sox9 activity by crosstalk with nuclear factor-kappaB and retinoic acid receptors.
Rockel JS; Kudirka JC; Guzi AJ; Bernier SM
Arthritis Res Ther; 2008; 10(1):R3. PubMed ID: 18182117
[TBL] [Abstract][Full Text] [Related]
7. A remote upstream element regulates tissue-specific expression of the rat aggrecan gene.
Doege K; Hall LB; McKinnon W; Chen L; Stephens DT; Garrison K
J Biol Chem; 2002 Apr; 277(16):13989-97. PubMed ID: 11834732
[TBL] [Abstract][Full Text] [Related]
8. The effect of bone morphogenetic protein-2 on rat intervertebral disc cells in vitro.
Tim Yoon S; Su Kim K; Li J; Soo Park J; Akamaru T; Elmer WA; Hutton WC
Spine (Phila Pa 1976); 2003 Aug; 28(16):1773-80. PubMed ID: 12923462
[TBL] [Abstract][Full Text] [Related]
9. Structural and functional analysis of the chick chondroitin sulfate proteoglycan (aggrecan) promoter and enhancer region.
Pirok EW; Li H; Mensch JR; Henry J; Schwartz NB
J Biol Chem; 1997 Apr; 272(17):11566-74. PubMed ID: 9111072
[TBL] [Abstract][Full Text] [Related]
10. Coordinate down-regulation of cartilage matrix gene expression in Bcl-2 deficient chondrocytes is associated with decreased SOX9 expression and decreased mRNA stability.
Kinkel MD; Horton WE
J Cell Biochem; 2003 Apr; 88(5):941-53. PubMed ID: 12616533
[TBL] [Abstract][Full Text] [Related]
11. JAK/STAT but not ERK1/ERK2 pathway mediates interleukin (IL)-6/soluble IL-6R down-regulation of Type II collagen, aggrecan core, and link protein transcription in articular chondrocytes. Association with a down-regulation of SOX9 expression.
Legendre F; Dudhia J; Pujol JP; Bogdanowicz P
J Biol Chem; 2003 Jan; 278(5):2903-12. PubMed ID: 12419823
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional suppression of Sox9 expression in chondrocytes by retinoic acid.
Sekiya I; Koopman P; Tsuji K; Mertin S; Harley V; Yamada Y; Shinomiya K; Niguji A; Noda M
J Cell Biochem Suppl; 2001; Suppl 36():71-8. PubMed ID: 11455572
[TBL] [Abstract][Full Text] [Related]
13. The new collagen gene COL27A1 contains SOX9-responsive enhancer elements.
Jenkins E; Moss JB; Pace JM; Bridgewater LC
Matrix Biol; 2005 May; 24(3):177-84. PubMed ID: 15922909
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor alpha and epidermal growth factor act additively to inhibit matrix gene expression by chondrocyte.
Klooster AR; Bernier SM
Arthritis Res Ther; 2005; 7(1):R127-38. PubMed ID: 15642133
[TBL] [Abstract][Full Text] [Related]
15. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene.
Lefebvre V; Huang W; Harley VR; Goodfellow PN; de Crombrugghe B
Mol Cell Biol; 1997 Apr; 17(4):2336-46. PubMed ID: 9121483
[TBL] [Abstract][Full Text] [Related]
16. Regulation of human COL9A1 gene expression. Activation of the proximal promoter region by SOX9.
Zhang P; Jimenez SA; Stokes DG
J Biol Chem; 2003 Jan; 278(1):117-23. PubMed ID: 12399468
[TBL] [Abstract][Full Text] [Related]
17. Expression of Sox9 and type IIA procollagen during attempted repair of articular cartilage damage in a transgenic mouse model of osteoarthritis.
Salminen H; Vuorio E; Säämänen AM
Arthritis Rheum; 2001 Apr; 44(4):947-55. PubMed ID: 11315934
[TBL] [Abstract][Full Text] [Related]
18. cis elements that control the expression of chick aggrecan.
Pirok EW; Henry J; Schwartz NB
J Biol Chem; 2001 May; 276(20):16894-903. PubMed ID: 11350977
[TBL] [Abstract][Full Text] [Related]
19. Dexamethasone enhances SOX9 expression in chondrocytes.
Sekiya I; Koopman P; Tsuji K; Mertin S; Harley V; Yamada Y; Shinomiya K; Nifuji A; Noda M
J Endocrinol; 2001 Jun; 169(3):573-9. PubMed ID: 11375127
[TBL] [Abstract][Full Text] [Related]
20. Regulation of type-II collagen gene expression during human chondrocyte de-differentiation and recovery of chondrocyte-specific phenotype in culture involves Sry-type high-mobility-group box (SOX) transcription factors.
Stokes DG; Liu G; Dharmavaram R; Hawkins D; Piera-Velazquez S; Jimenez SA
Biochem J; 2001 Dec; 360(Pt 2):461-70. PubMed ID: 11716775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
